IMMUNODEFICIENCY 15B
|
disease |
|
Disease or Syndrome
|
1
|
|
0.600 |
strong |
1.000 |
2 |
|
2013 |
2014 |
IMMUNODEFICIENCY 15A
|
disease |
|
Disease or Syndrome
|
1
|
1
|
0.400 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Direct Hyperbilirubinemia, Neonatal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Indirect Hyperbilirubinemia, Neonatal
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
4
|
1
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lung Melanoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Idiopathic pneumonia syndrome
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Recurrent fungal infections
|
phenotype |
|
Finding
|
20
|
2
|
0.100 |
None |
|
0 |
|
|
|
Hypertensive Retinopathy
|
disease |
Eye Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
24
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyperbilirubinemia, Neonatal
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
33
|
15
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Agammaglobulinemia
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
43
|
1
|
0.100 |
None |
|
0 |
|
|
|
Graft Rejection
|
phenotype |
|
Organ or Tissue Function
|
47
|
|
0.200 |
None |
1.000 |
2 |
|
2009 |
2010 |
Muscular Atrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Pathologic Function
|
49
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hyperoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Experimental Lung Inflammation
|
disease |
Infections; Respiratory Tract Diseases
|
Experimental Model of Disease
|
54
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Overnutrition
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
54
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Oral Mucositis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
59
|
16
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Skin toxicity
|
disease |
|
Disease or Syndrome
|
62
|
24
|
0.010 |
None |
1.000 |
1 |
1
|
2020 |
2020 |
Chronic diarrhea
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
62
|
9
|
0.100 |
None |
|
0 |
|
|
|
Malignant neoplasm of stomach stage IV
|
disease |
|
Neoplastic Process
|
78
|
7
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Disorder of tendon
|
group |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
79
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tendinopathy
|
disease |
Musculoskeletal Diseases; Wounds and Injuries
|
Disease or Syndrome
|
80
|
16
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.310 |
strong |
1.000 |
2 |
|
2014 |
2014 |
Splenic Marginal Zone B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
93
|
4
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2014 |
Primary immune deficiency disorder
|
group |
Immune System Diseases
|
Disease or Syndrome
|
93
|
23
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sinusitis
|
disease |
Infections; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
97
|
|
0.100 |
None |
|
0 |
|
|
|